Can the determination of serum procalcitonin be helpful in the differential diagnosis of an infection and an acute exacerbation in patients with a systemic autoimmune disease?;Může stanovení sérového prokalcitoninu pomoci v diferenciální diagnóze mezi infekcí a akutním zhoršením u pacientů se systé movým autoimunitním onemocněním?

Ceska Revmatologie

Volumn 18, Issue 1, 2010, Pages 4-11

  Šléglová, Olga ^a   Dejmkova H ^a   Uhrova J ^b  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Autoimmune disease; Bacterial and mycotic infection; C reactive protein; Corticosteroids; Immunosuppressive treatment; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PROCALCITONIN;

ACUTE DISEASE; ADULT; ANKYLOSING SPONDYLITIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; FEMALE; HUMAN; INFECTIOUS COMPLICATION; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PSORIATIC ARTHRITIS; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 77950955234     PISSN: 12107905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematodes during a 5-year period. A multicenter prospective study of 1000 patiens. European Working Party on Systemic Lupus erythematodes. Medicine 1999; 78:167-175.
2. Paton NI. Infections in systemic lupus erythematodes patients. Ann Acad Med Signapore 1997; 26: 694-700. (Pubitemid 128523452)
3. Joshua F, Riordan J, Sturgess A. Salmonella typhimurium mediastinal abscess in a patient with systemic lupus erythematosus. Lupus 2003; 12: 710-713 (Pubitemid 37173670)
4. Wu KC, Yao TC, Yeh KW, Huang JL. Osteomyelitis in patients with systemic lupus erythematosus. J Rheumatol 2004; 31:1340-1343 (Pubitemid 38879198)
5. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005; 11: 473-480
6. Mokart D, Merlin M, Sannini A, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005; 94: 767-773 (Pubitemid 40753992)
7. Malgorzata A, Verboon-Maciolek, Thijsen SFT, et al. Inflammatory mediators for diagnosis and treatment of sepsis in early infancy. Pediatr Res 2006, 59: 457-461
8. Assicot M, Gendrel D, Carsin H,et al. High serum procalcitonin concentrations in patiens with sepsis and infection. Lancet 1993; 341: 515-518.
9. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patiens. Critical Care 2006; 10: R1. (Pubitemid 47079170)
10. Dorizzi RM, Polati E, Sette P, et al. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 2006; 39(12): 1138-1143 (Pubitemid 44838574)
11. Selberg O, Hecker H, Martin M, et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein komplement 3a, and interleukin-6. Crit Care Med 2000; 28: 2793-2798
12. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19: 679-687.
13. Husová L, Husa P, Šenkyřík M, et al. Prokalcitonin jako indikátor infekce u pacientů s jaterní cirhózou. Vnitř Lék 2004; 50:153-156
14. Sitter T, Schmidt M, Schneider S, et al. Differential diagnosis of bacterial infection andinflammatory response in kidney diseases using procalcitonin. J Nephrol 2002; 15: 297-301.
15. Uzun G, Solmazgul E, Curuksulu H, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med 2007; 213(4): 305-312
16. Martinot M, Sordet C, Soubrier M, et al. Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patiens. Clin Exp Rheumatol 2005; 23: 303-310
17. Kazda A in ZimaT, et al. Laboratorní diagnostika.1.vyd., Galén, Praha 2002,829-844
18. Zima Tomáš, et al. Laboratorní diagnostika. 1. vyd., Galén, Praha 2002,839-844
19. Quintana G, Medina YF, Rojas C, et al. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus. J Clin Rheumatol 2008; 14(3): 138-42.
20. Brunkhorst R, Eberhardt OK, Haubitz M, et al.. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med 2000; 26 Suppl 2: S199-201.
21. Delevaux I, André M, Colombier M, et al. Can procalcitonin measurement help indifferentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003; 62 (4): 337-340
22. Tamaki K, Kogata Y, Sugiyama D, et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 2008; 35:114-119
23. Scire CA, Cavagna L, Perotti C, et al. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 2006; 24(2): 123-128
24. Eberhard OK, Haubitz M, Brunkhorst FM, et al.Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40(7): 1250-1256
25. Jensen JU, Lundgren B, Hein L, et al. The Procalcitonin and Survival Study (PASS)- a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic response to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size( target population): 1000 patients. BMC Infect Dis 2008: 91. online 2008 July 13.doi:10.1186/1471-2334-8-91.
26. Charles PE, Ladoire S, AHO S, et al.Serum procalcitonin elevation in critically ill patiens at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008; 26: 8: 38.
27. Tavares E, Maldonado R, Ojeda ML, et al. Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative versus gram-positive infections in leukopenic rats. Clin Diagn Lab Immunol 2005; 12:1085-1093 (Pubitemid 41324540)